Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Brandon Vazquez
WB
Brandon Vazquez
Wall Street Analyst
★★★☆☆
#1484
on 13Foresight · ranked by our own returns
43%
Success Rate
-0.6%
Average Return
16 of 37 calls profitable · -3.5% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 43% of Brandon Vazquez's ratings turned a profit when each position was held for 1 year — averaging -0.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

168 Buy 26 Hold 0 Sell
Brandon's Stock Coverage 27 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
IRTC
Irhythm Technologies
Jun 16, 2026 BUY Strong Buy
+61.5% avg upside
19 analysts
·
EW
Edwards Lifesciences
Jun 16, 2026 BUY Strong Buy
+11.7% avg upside
34 analysts
-2.1%
MDLN
Medline
Jun 12, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
-1.8%
CVRX
CVRx
Jun 09, 2026 BUY Strong Buy
+136.7% avg upside
9 analysts
·
TCMD
Tactile Systems Technology
Jun 03, 2026 BUY Strong Buy
+54.0% avg upside
8 analysts
+6.0%
ZTS
Zoetis
Jun 03, 2026 BUY Buy
+71.4% avg upside
22 analysts
-0.4%
RMD
Resmed
Jun 03, 2026 BUY Buy
+25.4% avg upside
27 analysts
+3.7%
MDT
Medtronic
Jun 03, 2026 BUY Buy
+23.5% avg upside
38 analysts
+1.8%
ALGN
Align Tech
Jun 03, 2026 BUY Strong Buy
+56.4% avg upside
21 analysts
+7.3%
CBLL
Ceribell, Inc.
Jun 03, 2026 BUY Strong Buy
+38.7% avg upside
8 analysts
+0.6%
PRCT
PROCEPT BioRobotics
Jun 03, 2026 BUY Buy
+79.5% avg upside
16 analysts
-15.1%
ELAN
Elanco Animal Health
Jun 03, 2026 BUY Strong Buy
+24.1% avg upside
18 analysts
-1.4%
HTFL
HeartFlow, Inc.
May 15, 2026 BUY Strong Buy
+9.2% avg upside
8 analysts
+8.3%
NVST
Envista Holdings
May 07, 2026 BUY Buy
+12.8% avg upside
19 analysts
-4.4%
XRAY
DENTSPLY SIRONA
May 06, 2026 HOLD Buy
+170.6% avg upside
25 analysts
-5.1%
HSIC
Henry Schein
May 05, 2026 HOLD Buy
+7.4% avg upside
25 analysts
$74.00
7.31% Downside
+7.5%
TRUP
Trupanion
May 01, 2026 BUY Strong Buy
+73.6% avg upside
19 analysts
-2.1%
DXCM
Dexcom
May 01, 2026 BUY Strong Buy
+38.6% avg upside
32 analysts
$59.00
18.60% Downside
+19.2%
TSE:STMN
Stearman Resources, Inc.
Apr 29, 2026 BUY Strong Buy
1 analyst
·
NEOG
Neogen
Apr 27, 2026 HOLD Buy
+148.1% avg upside
6 analysts
-8.0%
ISRG
Intuitive Surgical
Apr 22, 2026 BUY Strong Buy
+29.4% avg upside
36 analysts
$451.00
10.83% Upside
-15.9%
ABT
Abbott Laboratories
Apr 17, 2026 BUY Strong Buy
+31.2% avg upside
35 analysts
-8.6%
PODD
Insulet
Feb 18, 2026 BUY Strong Buy
+79.0% avg upside
32 analysts
-42.0%
PEN
Penumbra
Jan 17, 2026 HOLD Buy
+4.4% avg upside
23 analysts
-11.1%
ENOV
Enovis
Jan 13, 2026 BUY Strong Buy
+216.5% avg upside
37 analysts
+0.9%
GKOS
Glaukos
Oct 30, 2025 BUY Strong Buy
+5.5% avg upside
20 analysts
+64.0%
CH:STMN
Straumann Holding AG
Oct 29, 2025 BUY Buy
+19.9% avg upside
13 analysts
·
🔒 22 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Brandon Vazquez — Frequently Asked Questions
How accurate are Brandon Vazquez's stock ratings?
Based on the calls 13Foresight could measure, about 43% of Brandon's ratings were profitable over a one-year hold, with an average return of -0.6% per rating, or -3.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Brandon ranked on 13Foresight?
Brandon Vazquez is currently ranked #1484 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Brandon cover?
Brandon most recently has ratings on IRTC, EW, MDLN, CVRX, TCMD, ZTS, RMD, MDT, ALGN, CBLL, PRCT, ELAN and 15 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.